Market Access Insight, Latest, Strategic Consultancy, Thought Leadership

Prescription pending

In PharmaTimes, V4H’s Roshani Perera explains why NICE medicines struggle to reach patients and what can be done about it

In the latest issue of PharmaTimes, Visions4Health’s Commercial Director – Roshani Perera – has authored a thought leadership article explaining why healthcare innovation is on hold as NICE medicines struggle to reach patients. She discusses the question can industry, government and providers finally bridge the gap between approval and access? and suggests five partnership opportunities between the life sciences sector and the NHS to improve uptake of innovation. Read all about it here.

Share

Related News & Insight

V4H is committed to running its business responsibly and sustainably, considering our full impact on the environment.
V4H’s MD has authored an article in Pharmafile about the need to create multi-collaboration communities to tackle the biggest innovation and access challenges on the EU horizon.
The Gateway to Local Adoption series – topical, quick-read opinion pieces authored by our very own Healthcare System Council…
The Gateway to Local Adoption series – topical, quick-read opinion pieces authored by our very own Healthcare System Council…
V4H’s MD has authored an article in PharmaTimes about building market access strategies that work in today’s NHS.
Visions 4 Health Masked Icon - Green - Mobile

Speak to a Member of Our Team

We’re happy to provide more details and answer any questions you might have.